Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution

Abstract Molecular Dynamic (MD) simulations are very effective in the discovery of nanomedicines for treating cancer, but these are computationally expensive and time-consuming. Existing studies integrating machine learning (ML) into MD simulation to enhance the process and enable efficient analysis...

Full description

Bibliographic Details
Main Authors: Md Raisul Kibria, Refo Ilmiya Akbar, Poonam Nidadavolu, Oksana Havryliuk, Sébastien Lafond, Sepinoud Azimi
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-27729-7
_version_ 1797952596965588992
author Md Raisul Kibria
Refo Ilmiya Akbar
Poonam Nidadavolu
Oksana Havryliuk
Sébastien Lafond
Sepinoud Azimi
author_facet Md Raisul Kibria
Refo Ilmiya Akbar
Poonam Nidadavolu
Oksana Havryliuk
Sébastien Lafond
Sepinoud Azimi
author_sort Md Raisul Kibria
collection DOAJ
description Abstract Molecular Dynamic (MD) simulations are very effective in the discovery of nanomedicines for treating cancer, but these are computationally expensive and time-consuming. Existing studies integrating machine learning (ML) into MD simulation to enhance the process and enable efficient analysis cannot provide direct insights without the complete simulation. In this study, we present an ML-based approach for predicting the solvent accessible surface area (SASA) of a nanoparticle (NP), denoting its efficacy, from a fraction of the MD simulations data. The proposed framework uses a time series model for simulating the MD, resulting in an intermediate state, and a second model to calculate the SASA in that state. Empirically, the solution can predict the SASA value 260 timesteps ahead 7.5 times faster with a very low average error of 1956.93. We also introduce the use of an explainability technique to validate the predictions. This work can reduce the computational expense of both processing and data size greatly while providing reliable solutions for the nanomedicine design process.
first_indexed 2024-04-10T22:48:49Z
format Article
id doaj.art-fdabd8d8a50f4c068b1ae9ae462053d5
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-10T22:48:49Z
publishDate 2023-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-fdabd8d8a50f4c068b1ae9ae462053d52023-01-15T12:10:32ZengNature PortfolioScientific Reports2045-23222023-01-0113111310.1038/s41598-023-27729-7Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solutionMd Raisul Kibria0Refo Ilmiya Akbar1Poonam Nidadavolu2Oksana Havryliuk3Sébastien Lafond4Sepinoud Azimi5Faculty of Science and Engineering, Åbo Akademi UniversityFaculty of Science and Engineering, Åbo Akademi UniversityFaculty of Science and Engineering, Åbo Akademi UniversityFaculty of Science and Engineering, Åbo Akademi UniversityFaculty of Science and Engineering, Åbo Akademi UniversityFaculty of Science and Engineering, Åbo Akademi UniversityAbstract Molecular Dynamic (MD) simulations are very effective in the discovery of nanomedicines for treating cancer, but these are computationally expensive and time-consuming. Existing studies integrating machine learning (ML) into MD simulation to enhance the process and enable efficient analysis cannot provide direct insights without the complete simulation. In this study, we present an ML-based approach for predicting the solvent accessible surface area (SASA) of a nanoparticle (NP), denoting its efficacy, from a fraction of the MD simulations data. The proposed framework uses a time series model for simulating the MD, resulting in an intermediate state, and a second model to calculate the SASA in that state. Empirically, the solution can predict the SASA value 260 timesteps ahead 7.5 times faster with a very low average error of 1956.93. We also introduce the use of an explainability technique to validate the predictions. This work can reduce the computational expense of both processing and data size greatly while providing reliable solutions for the nanomedicine design process.https://doi.org/10.1038/s41598-023-27729-7
spellingShingle Md Raisul Kibria
Refo Ilmiya Akbar
Poonam Nidadavolu
Oksana Havryliuk
Sébastien Lafond
Sepinoud Azimi
Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution
Scientific Reports
title Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution
title_full Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution
title_fullStr Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution
title_full_unstemmed Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution
title_short Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution
title_sort predicting efficacy of drug carrier nanoparticle designs for cancer treatment a machine learning based solution
url https://doi.org/10.1038/s41598-023-27729-7
work_keys_str_mv AT mdraisulkibria predictingefficacyofdrugcarriernanoparticledesignsforcancertreatmentamachinelearningbasedsolution
AT refoilmiyaakbar predictingefficacyofdrugcarriernanoparticledesignsforcancertreatmentamachinelearningbasedsolution
AT poonamnidadavolu predictingefficacyofdrugcarriernanoparticledesignsforcancertreatmentamachinelearningbasedsolution
AT oksanahavryliuk predictingefficacyofdrugcarriernanoparticledesignsforcancertreatmentamachinelearningbasedsolution
AT sebastienlafond predictingefficacyofdrugcarriernanoparticledesignsforcancertreatmentamachinelearningbasedsolution
AT sepinoudazimi predictingefficacyofdrugcarriernanoparticledesignsforcancertreatmentamachinelearningbasedsolution